Y. Sumida
Epidemiology · 2014–2017
A researcher in the Science corpus: 3 papers; trusts 1 researcher and is trusted by 2 researchers here, as inferred from the citation graph.
Subfields
- Epidemiology — 60 citations into it; #1,287 of 2,148 by trust here, #1,461 by citations
- Hepatology — 38 citations into it; #70 of 151 by trust here, #150 by citations
Whom Y. Sumida trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Y. Sumida overall
Papers from Y. Sumida's perspective
Ordered by how strongly the researchers Y. Sumida trusts endorse each paper. Same corpus, a different order for every researcher.
- Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults (Alimentary Pharmacology and Therapeutics)
- Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study. (The Lancet)
- A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C (Hepatology)
- The epidemiology of nonalcoholic fatty liver disease: a global perspective. (Seminars in liver disease (Print))
- Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography. (Gastroenterology)
- Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease (Gut)
- Nonalcoholic Steatohepatitis: Definition and Pathology (Seminars in liver disease (Print))
- Magnetic resonance elastography for the noninvasive staging of liver fibrosis. (Gastroenterology)
- Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. (Ultrasound in Medicine and Biology)
- Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: Results of a randomized trial (Hepatology)
Their papers
- Current and future pharmacological therapies for NAFLD/NASH (2017) — 622 citations
- Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography. (2016) — 745 citations
- Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. (2014) — 615 citations